Thermo Fisher Reports 15 Percent Rise in Q4 Revenues; Q Exactive Gains Foothold in Q-TOF Market | GenomeWeb

This story originally ran on Feb. 1.

Thermo Fisher Scientific this week reported $3.13 billion in Q4 2011 revenues, up 15 percent from $2.72 billion in Q4 2010 and beating Wall Street estimates of $3.08 billion.

On a conference call to discuss the financial results, president and CEO Marc Casper highlighted the launch of new products, including the Q Exactive mass spectrometer, as a "key aspect" of the company's revenue growth.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.